Crescent Capital Partners
Peter Scrine is a seasoned professional with extensive experience in business development and management within the media and private equity sectors. As the Business Development Director at Crescent Capital Partners since September 2007, Peter has contributed to one of Australasia's leading middle market private equity firms, focusing on investments in companies with enterprise values between A$50 million and A$300 million. Prior to this role, Peter served as Chairman of the Arts Board at Circus Monoxide from August 2008 to June 2015, promoting animal-free contemporary circus in Australia. Peter also held the position of General Manager for Win Radio at WIN Corporation Pty Ltd from 2003 to 2007, where responsibilities included change management and revenue development. At Austereo, from 1996 to February 2003, Peter was the National Partnership Director, creating multimedia advertising partnerships. Educational qualifications include an Advanced Diploma of Management and an Advanced Diploma of Marketing, both earned from Sydney Technical College and Illawarra Technical College, respectively.
This person is not in any teams
Crescent Capital Partners
Crescent Capital Partners (Crescent) is a Sydney-based private equity firm investing in middle-market companies located in Australia and New Zealand with enterprise values between A$100 million and A$500 million. Crescent was formed in 2000 and has established itself as one of Australasia’s leading middle market private equity firms with its last three funds ranked as top quartile global funds (measured in either USD or AUD), as measured by Cambridge Associates. Crescent’s investment focus is on high-growth companies and sectors, or in industries that are undergoing structural change or that lend themselves to consolidation. Crescent’s role is to accelerate and support the senior management teams of these businesses in reaching their aspirational targets and goals. Crescent has a differentiated investment process that combines thematic and proprietary deal sourcing, with a disciplined and analytical approach to investing and a proactive approach to driving value at portfolio companies. Crescent has particular experience and skills in financial services, healthcare, branded and industrial businesses. In particular, Crescent has been the most active private equity manager in healthcare transactions in Australia measured by number of investments made in the past 10 years. Crescent has had a strong track record in delivering superior returns to investors through successful exits. Crescent is now investing our $1 billion Crescent VII (2023 vintage).